Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer

[1]  Katherine Sellers,et al.  Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. , 2022, Cell metabolism.

[2]  Yuanyuan Yang,et al.  Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity. , 2022, ACS nano.

[3]  Dan Li,et al.  Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer , 2021, Frontiers in Oncology.

[4]  Ziyang Cao,et al.  A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy. , 2021, ACS nano.

[5]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[6]  Gen Li,et al.  Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses , 2021, Nature Cell Biology.

[7]  H. Chi,et al.  LCK senses asparagine for T cell activation , 2021, Nature Cell Biology.

[8]  T. Brummer,et al.  Immune modulatory effects of oncogenic KRAS in cancer , 2020, Nature Communications.

[9]  In-kyu Lee,et al.  Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity. , 2020, Molecular cell.

[10]  Jun Yu,et al.  In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. , 2020, Gastroenterology.

[11]  Hiroyuki Koide,et al.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles , 2020, Advanced Drug Delivery Reviews.

[12]  J. Powell,et al.  Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion , 2019, Science.

[13]  A. Cheng,et al.  Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma , 2019, Gut.

[14]  R. DePinho,et al.  KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. , 2019, Cancer cell.

[15]  N. Matsumura,et al.  Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation , 2018, Nature Communications.

[16]  Charles M. Perou,et al.  Asparagine bioavailability governs metastasis in a model of breast cancer , 2018, Nature.

[17]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[18]  Jun Yu,et al.  SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. , 2016, Gastroenterology.

[19]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[20]  T. Graeber,et al.  Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor , 2016, Nature Communications.

[21]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[22]  Amber J. Giles,et al.  Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy , 2014, Science Translational Medicine.

[23]  S. Dey,et al.  CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. , 2013, Cancer cell.

[24]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[25]  Mario Huerta,et al.  Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN , 2003, Nucleic Acids Res..

[26]  Xavier Messeguer,et al.  PROMO: detection of known transcription regulatory elements using species-tailored searches , 2002, Bioinform..

[27]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[28]  Jun Yu,et al.  Determination of amino acids in colon cancer cells by using UHPLC-MS/MS and [U-13C5]-glutamine as the isotope tracer. , 2017, Talanta.